Federation des caisses Desjardins du Quebec
LENZ icon

Federation des caisses Desjardins du Quebec’s LENZ Therapeutics LENZ Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$726 Hold
128
– – ﹤0.01% 2842
2026
Q1 		$1.17K Hold
128
– – ﹤0.01% 2740
2025
Q4 		$2.04K Hold
128
– – ﹤0.01% 2596
2025
Q3 		$5.96K Buy
128
+100
+357% +$3.68K ﹤0.01% 2411
2025
Q2 		$821 Hold
28
– – ﹤0.01% 2528
2025
Q1 		$720 Hold
28
– – ﹤0.01% 2458
2024
Q4 		$808 Hold
28
– – ﹤0.01% 2342
2024
Q3 		$665 Hold
28
– – ﹤0.01% 2364
2024
Q2 		$484 Hold
28
– – ﹤0.01% 2259
2024
Q1 		$625 Sell
28
-1
-3% -$21 ﹤0.01% 2223
2023
Q4 		$524 Hold
29
– – ﹤0.01% 2198
2023
Q3 		$496 Hold
29
– – ﹤0.01% 2208
2023
Q2 		$520 Hold
29
– – ﹤0.01% 2190
2023
Q1 		$490 Hold
29
– – ﹤0.01% 2214
2022
Q4 		$664 Hold
29
– – ﹤0.01% 2327
2022
Q3 		$634 Hold
29
– – ﹤0.01% 2385
2022
Q2 		$550 Hold
29
– – ﹤0.01% 2434
2022
Q1 		$1.02K Hold
29
– – ﹤0.01% 2428
2021
Q4 		$2.49K Hold
29
– – ﹤0.01% 2328
2021
Q3 		$3.28K Buy
+29
New +$4.29K ﹤0.01% 2345

Other funds holding LENZ

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's LENZ Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 128 shares worth $726. The position accounts for ﹤0.01% of the portfolio, ranked #2842.

Federation des caisses Desjardins du Quebec first reported a position in LENZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.96K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 128 shares of LENZ Therapeutics worth $726 as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its LENZ Therapeutics share count unchanged in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2842 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Federation des caisses Desjardins du Quebec's LENZ Therapeutics position peaked at $5.96K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.